Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.540
-0.040 (-2.53%)
At close: Jan 30, 2026, 4:00 PM EST
1.513
-0.027 (-1.75%)
After-hours: Jan 30, 2026, 7:47 PM EST

Metagenomi Therapeutics Revenue

Metagenomi Therapeutics had revenue of $8.66M in the quarter ending September 30, 2025, a decrease of -24.80%. This brings the company's revenue in the last twelve months to $30.91M, down -43.88% year-over-year. In the year 2024, Metagenomi Therapeutics had annual revenue of $52.30M with 16.84% growth.

Revenue (ttm)
$30.91M
Revenue Growth
-43.88%
P/S Ratio
1.85
Revenue / Employee
$249,298
Employees
124
Market Cap
57.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202452.30M7.54M16.84%
Dec 31, 202344.76M27.56M160.21%
Dec 31, 202217.20M16.96M6,978.19%
Dec 31, 2021243.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MGX News

More News